Syfe H2 2025 Market Outlook: From US Dominance to Global Resurgence
The first half of 2025 marked a turning point in global markets. After years of US equity dominance, international markets surged ahead, reflecting deeper structural shifts.
Options Trading in Singapore: The Complete Beginner’s Guide (2025)
This beginner-friendly guide how options work and how Singaporeans can place their first options trade with confidence.
Hong Kong Tech Stock Investing in Singapore: Practical Guide
If you’re a Singaporean investor, Hong Kong tech stocks can be a...
CSPX vs VWRA vs IWDA vs SPYL vs VUAA: Which UCITS ETFs to Invest In?
UCITS, short for ‘undertakings for collective investment in transferable securities’, is a...
Healthcare Innovation in Singapore: Positioning for Growth Amid Digital Acceleration and Regulatory Reform
This article examines the current landscape of the healthcare industry in Singapore, market dynamics, key growth drivers, and challenges in this rapidly evolving sector.
Syfe Core Portfolios Monthly Update: November 2025 Outperformance
November saw a pause in global markets after a strong run earlier in the year. Against this backdrop, our portfolios generally outperformed their benchmarks.
Singapore’s Rise as a Global Fintech Powerhouse: What It Means for Your Investment Strategy
Singapore has firmly established itself as a global leader in the Fintech industry. Find out how this shapes new opportunities for investors.
Income Tax Relief: 5 Ways to Lower Your Payable Tax in Singapore
Singapore offers a variety of tax relief options designed to ease the...
CPF vs SRS Top-Ups: Which to Choose and What’s the Difference?
The CPF SA and SRS are designed to help you save, but they have different rules & benefits. Learn more about their differences.
Making the Most of SRS as a Foreigner in Singapore
As a foreigner (or expat) in Singapore navigating financial planning can feel like a journey full of unknowns. Here's how the SRS can help you invest for the future while reducing taxes.
Syfe Core Portfolios Monthly Update: November 2025 Outperformance
November saw a pause in global markets after a strong run earlier in the year. Against this backdrop, our portfolios generally outperformed their benchmarks.
Healthcare Innovation Portfolio: Balancing Exposure and Capturing Upsides
Syfe's Healthcare Innovation thematic portfolio invests in companies at the cutting edge of genomics, biotechnology, pharmaceuticals, and more.
ESG Investing: Investing For Change
Want to help create a more sustainable future? One way to start is by investing in the Syfe Select ESG & Clean Energy portfolio.
The Fed Delivers Its First Rate Cut of 2025: What This Means for Investors
The US Federal Reserve has cut interest rates by 25 bps. With...
August 2025 Market Update: Global Markets Rally as Fed Rate Cut Looms
Global markets maintained their momentum through August, supported by resilient earnings and expectations of a Fed rate cut. Here's what you need to know.
Beware of scammers impersonating Syfe and its officers or employees
Stay vigilant. Syfe has received reports of WhatsApp messages impersonating us
